|
1
|
Gomes MB and Cobas RA: Post-transplant
diabetes mellitus. Diabetol Metab Syndr. 1:142009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jenssen T and Hartmann A: Emerging
treatments for post-transplantation diabetes mellitus. Nat Rev
Nephrol. 11:465–477. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cosio FG, Kudva Y, van der Velde M, Larson
TS, Textor SC, Griffin MD and Stegall MD: New onset hyperglycemia
and diabetes are associated with increased cardiovascular risk
after kidney transplantation. Kidney Int. 67:2415–2421. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Revanur VK, Jardine AG, Kingsmore DB,
Jaques BC, Hamilton DH and Jindal RM: Influence of diabetes
mellitus on patient and graft survival in recipients of kidney
transplantation. Clin Transplant. 15:89–94. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kasiske BL, Snyder JJ, Gilbertson D and
Matas AJ: Diabetes mellitus after kidney transplantation in the
United States. Am J Transplant. 3:178–185. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chowdhury TA: Post-transplant diabetes
mellitus. Clin Med (Lond). 19:392–395. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bloom RD and Crutchlow MF: New-onset
diabetes mellitus in the kidney recipient: Diagnosis and management
strategies. Clin J Am Soc Nephrol. 3 (Suppl 2):S38–S48. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Vincenti F, Friman S, Scheuermann E,
Rostaing L, Jenssen T, Campistol JM, Uchida K, Pescovitz MD,
Marchetti P, Tuncer M, et al: Results of an international,
randomized trial comparing glucose metabolism disorders and outcome
with cyclosporine versus tacrolimus. Am J Transplant. 7:1506–1514.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chakkera HA, Kudva Y and Kaplan B:
Calcineurin inhibitors: Pharmacologic mechanisms impacting both
insulin resistance and insulin secretion leading to glucose
dysregulation and diabetes mellitus. Clin Pharmacol Ther.
101:114–120. 2017. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
van Hooff JP, Christiaans MH and van
Duijnhoven EM: Tacrolimus and posttransplant diabetes mellitus in
renal transplantation. Transplantation. 79:1465–1469. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Caillard S, Eprinchard L, Perrin P, Braun
L, Heibel F, Moreau F, Kessler L and Moulin B: Incidence and risk
factors of glucose metabolism disorders in kidney transplant
recipients: Role of systematic screening by oral glucose tolerance
test. Transplantation. 91:757–764. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ishihara H, Asano T, Tsukuda K, Katagiri
H, Inukai K, Anai M, Kikuchi M, Yazaki Y, Miyazaki JI and Oka Y:
Pancreatic beta cell line MIN6 exhibits characteristics of glucose
metabolism and glucose-stimulated insulin secretion similar to
those of normal islets. Diabetologia. 36:1139–1145. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Huang X, Liu G, Guo J and Su Z: The
PI3K/AKT pathway in obesity and type 2 diabetes. Int J Biol Sci.
14:1483–1496. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Engelman JA, Luo J and Cantley LC: The
evolution of phosphatidylinositol 3-kinases as regulators of growth
and metabolism. Nat Rev Genet. 7:606–619. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wullschleger S, Loewith R and Hall MN: TOR
signaling in growth and metabolism. Cell. 124:471–484. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Redmon JB, Olson LK, Armstrong MB, Greene
MJ and Robertson RP: Effects of tacrolimus (FK506) on human insulin
gene expression, insulin mRNA levels, and insulin secretion in
HIT-T15 cells. J Clin Invest. 98:2786–2793. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Johnson JD, Ao Z, Ao P, Li H, Dai LJ, He
Z, Tee M, Potter KJ, Klimek AM, Meloche RM, et al: Different
effects of FK506, rapamycin, and mycophenolate mofetil on
glucose-stimulated insulin release and apoptosis in human islets.
Cell Transplant. 18:833–845. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sakata N, Egawa S, Sumi S and Unno M:
Optimization of glucose level to determine the stimulation index of
isolated rat islets. Pancreas. 36:417–423. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Prokai A, Fekete A, Pasti K, Rusai K,
Banki NF, Reusz G and Szabo AJ: The importance of different
immunosuppressive regimens in the development of posttransplant
diabetes mellitus. Pediatr Diabetes. 13:81–91. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rangel EB: Tacrolimus in pancreas
transplant: A focus on toxicity, diabetogenic effect and drug-drug
interactions. Expert Opin Drug Metab Toxicol. 10:1585–1605. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rysz J, Franczyk B, Radek M,
Ciałkowska-Rysz A and Gluba-Brzózka A: Diabetes and cardiovascular
risk in renal transplant patients. Int J Mol Sci. 22:34222021.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Drachenberg CB, Klassen DK, Weir MR,
Wiland A, Fink JC, Bartlett ST, Cangro CB, Blahut S and
Papadimitriou JC: Islet cell damage associated with tacrolimus and
cyclosporine: Morphological features in pancreas allograft biopsies
and clinical correlation. Transplantation. 68:396–402. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Soleimanpour SA, Crutchlow MF, Ferrari AM,
Raum JC, Groff DN, Rankin MM, Liu C, De León DD, Naji A, Kushner JA
and Stoffers DA: Calcineurin signaling regulates human islet
{beta}-cell survival. J Biol Chem. 285:40050–40059. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Speckmann T, Sabatini PV, Nian C, Smith RG
and Lynn FC: Npas4 transcription factor expression is regulated by
calcium signaling pathways and prevents tacrolimus-induced
cytotoxicity in pancreatic beta cells. J Biol Chem. 291:2682–2695.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sottero B, Gargiulo S, Russo I, Barale C,
Poli G and Cavalot F: Postprandial dysmetabolism and oxidative
stress in type 2 diabetes: Pathogenetic mechanisms and therapeutic
strategies. Med Res Rev. 35:968–1031. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Rehman K and Akash MSH: Mechanism of
generation of oxidative stress and pathophysiology of type 2
diabetes mellitus: How are they interlinked? J Cell Biochem.
118:3577–3585. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Aouacheri O, Saka S, Krim M, Messaadia A
and Maidi I: The investigation of the oxidative stress-related
parameters in type 2 diabetes mellitus. Can J Diabetes. 39:44–49.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pérez Fernandez R, Martín Mateo MC, De
Vega L, Bustamante Bustamante J, Herrero M and Bustamante Munguira
E: Antioxidant enzyme determination and a study of lipid
peroxidation in renal transplantation. Ren Fail. 24:353–359. 2002.
View Article : Google Scholar
|
|
30
|
Tsikas D: Assessment of lipid peroxidation
by measuring malondialdehyde (MDA) and relatives in biological
samples, Analytical and biological challenges. Anal Biochem.
524:13–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Noberasco G, Odetti P, Boeri D, Maiello M
and Adezati L: Malondialdehyde (MDA) level in diabetic subjects.
Relationship with blood glucose and glycosylated hemoglobin. Biomed
Pharmacother. 45:193–196. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yepes-Calderón M, Sotomayor CG, Gomes-Neto
AW, Gans ROB, Berger SP, Rimbach G, Esatbeyoglu T, Rodrigo R,
Geleijnse JM, Navis GJ and Bakker SJL: Plasma malondialdehyde and
risk of new-onset diabetes after transplantation in renal
transplant recipients: A prospective cohort study. J Clin Med.
8:4532019. View Article : Google Scholar
|
|
33
|
Jin J, Jin L, Luo K, Lim SW, Chung BH and
Yang CW: Effect of empagliflozin on tacrolimus-induced pancreas
islet dysfunction and renal injury. Am J Transplant. 17:2601–2616.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ho E, Karimi Galougahi K, Liu CC, Bhindi R
and Figtree GA: Biological markers of oxidative stress:
Applications to cardiovascular research and practice. Redox Biol.
1:483–491. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Vivanco I and Sawyers CL: The
phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev
Cancer. 2:489–501. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
36
|
Engelman JA: Targeting PI3K signalling in
cancer: Opportunities, challenges and limitations. Nat Rev Cancer.
9:550–562. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Whiteman EL, Cho H and Birnbaum MJ: Role
of Akt/protein kinase B in metabolism. Trends Endocrinol Metab.
13:444–451. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Asano T, Fujishiro M, Kushiyama A, Nakatsu
Y, Yoneda M, Kamata H and Sakoda H: Role of phosphatidylinositol
3-kinase activation on insulin action and its alteration in
diabetic conditions. Biol Pharm Bull. 30:1610–1616. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Matheny RW Jr and Adamo ML: PI3K p110
alpha and p110 beta have differential effects on Akt activation and
protection against oxidative stress-induced apoptosis in myoblasts.
Cell Death Differ. 17:677–688. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chen XW, Leto D, Xiong T, Yu G, Cheng A,
Decker S and Saltiel AR: A Ral GAP complex links PI 3-kinase/Akt
signaling to RalA activation in insulin action. Mol Biol Cell.
22:141–152. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Sudarsanam S and Johnson DE: Functional
consequences of mTOR inhibition. Curr Opin Drug Discov Devel.
13:31–40. 2010.PubMed/NCBI
|
|
42
|
Rodriguez-Rodriguez AE, Donate-Correa J,
Rovira J, Cuesto G, Luis-Ravelo D, Fernandes MX, Acevedo-Arozena A,
Diekmann F, Acebes A, Torres A and Porrini E: Inhibition of the
mTOR pathway: A new mechanism of β cell toxicity induced by
tacrolimus. Am J Transplant. 19:3240–3249. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Slobodin B, Han R, Calderone V, Vrielink
JAFO, Loayza-Puch F, Elkon R and Agami R: Transcription impacts the
efficiency of mRNA Translation via Co-transcriptional N6-adenosine
Methylation. Cell. 169:326–337.e12. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Juan Khong M and Ping Chong Ch: Prevention
and management of new-onset diabetes mellitus in kidney
transplantation. Neth J Med. 72:127–134. 2014.PubMed/NCBI
|
